Clinical Study on the Immunomodulatory Effect of Eprolidone on Patients With Chronic Heart Failure
Condition(s):Chronic Heart Failure PatientsLast Updated:June 29, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Chronic Heart Failure PatientsLast Updated:June 29, 2023Not yet recruiting
Condition(s):Heart Failure With Preserved Ejection Fraction; Renal DenervationLast Updated:February 1, 2024Recruiting
Condition(s):Sepsis; Blood PurificationLast Updated:February 7, 2024Not yet recruiting
Condition(s):SepsisLast Updated:February 7, 2024Not yet recruiting
Condition(s):Portal Vein Thrombosis; Liver CirrhosisLast Updated:October 25, 2022Recruiting
Condition(s):Brucelloses; Epidemic Hemorrhagic Fever; Kala-AzarLast Updated:May 14, 2020Recruiting
Condition(s):Intestinal Infection; Clostridioides Difficile Infection; Antibiotic-associated DiarrheaLast Updated:February 29, 2024Recruiting
Condition(s):Thrombocytopenia; Stem Cell Transplant ComplicationsLast Updated:January 11, 2024Not yet recruiting
Condition(s):Respiratory DiseaseLast Updated:August 2, 2022Recruiting
Condition(s):Idiopathic Membranous NephropathyLast Updated:May 18, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.